nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A2—Cladribine—multiple sclerosis	0.261	0.535	CbGbCtD
Norepinephrine—SLC22A1—Cladribine—multiple sclerosis	0.227	0.465	CbGbCtD
Norepinephrine—POU5F1—cerebellum—multiple sclerosis	0.0169	0.11	CbGeAlD
Norepinephrine—SLC18A1—nervous system—multiple sclerosis	0.00665	0.0433	CbGeAlD
Norepinephrine—SLC18A1—central nervous system—multiple sclerosis	0.0064	0.0417	CbGeAlD
Norepinephrine—Isoprenaline—MAPK1—multiple sclerosis	0.00615	0.808	CrCbGaD
Norepinephrine—SLC6A2—nerve—multiple sclerosis	0.00576	0.0375	CbGeAlD
Norepinephrine—DRD2—nerve—multiple sclerosis	0.00525	0.0342	CbGeAlD
Norepinephrine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00522	0.034	CbGeAlD
Norepinephrine—SLC18A1—brain—multiple sclerosis	0.00508	0.0331	CbGeAlD
Norepinephrine—PAH—nervous system—multiple sclerosis	0.00477	0.0311	CbGeAlD
Norepinephrine—PAH—central nervous system—multiple sclerosis	0.00459	0.0299	CbGeAlD
Norepinephrine—SLC18A2—brainstem—multiple sclerosis	0.00405	0.0264	CbGeAlD
Norepinephrine—PAH—brain—multiple sclerosis	0.00365	0.0237	CbGeAlD
Norepinephrine—SLC18A2—medulla oblongata—multiple sclerosis	0.00283	0.0184	CbGeAlD
Norepinephrine—SLC18A2—midbrain—multiple sclerosis	0.00258	0.0168	CbGeAlD
Norepinephrine—SLC6A2—brainstem—multiple sclerosis	0.00247	0.0161	CbGeAlD
Norepinephrine—ADRA1A—brainstem—multiple sclerosis	0.0023	0.015	CbGeAlD
Norepinephrine—DRD2—brainstem—multiple sclerosis	0.00225	0.0147	CbGeAlD
Norepinephrine—DRD2—retina—multiple sclerosis	0.00217	0.0142	CbGeAlD
Norepinephrine—ADRA1B—nervous system—multiple sclerosis	0.00214	0.014	CbGeAlD
Norepinephrine—SLC18A2—nervous system—multiple sclerosis	0.00212	0.0138	CbGeAlD
Norepinephrine—ADRA1D—nervous system—multiple sclerosis	0.0021	0.0137	CbGeAlD
Norepinephrine—ADRA1B—central nervous system—multiple sclerosis	0.00206	0.0134	CbGeAlD
Norepinephrine—SLC18A2—central nervous system—multiple sclerosis	0.00204	0.0133	CbGeAlD
Norepinephrine—SLC22A5—retina—multiple sclerosis	0.00202	0.0132	CbGeAlD
Norepinephrine—ADRA1D—central nervous system—multiple sclerosis	0.00202	0.0131	CbGeAlD
Norepinephrine—SLC18A2—cerebellum—multiple sclerosis	0.002	0.013	CbGeAlD
Norepinephrine—SLC6A2—medulla oblongata—multiple sclerosis	0.00172	0.0112	CbGeAlD
Norepinephrine—ADRA1B—brain—multiple sclerosis	0.00164	0.0107	CbGeAlD
Norepinephrine—SLC18A2—brain—multiple sclerosis	0.00162	0.0106	CbGeAlD
Norepinephrine—ADRA1D—brain—multiple sclerosis	0.0016	0.0104	CbGeAlD
Norepinephrine—SLC22A1—nervous system—multiple sclerosis	0.00158	0.0103	CbGeAlD
Norepinephrine—ADRA2C—medulla oblongata—multiple sclerosis	0.00153	0.00995	CbGeAlD
Norepinephrine—ADRB1—nervous system—multiple sclerosis	0.00152	0.00992	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—multiple sclerosis	0.00152	0.00992	CbGeAlD
Norepinephrine—SLC22A3—nervous system—multiple sclerosis	0.00151	0.00984	CbGeAlD
Norepinephrine—ADRB1—central nervous system—multiple sclerosis	0.00147	0.00955	CbGeAlD
Norepinephrine—Extravasation—Cladribine—multiple sclerosis	0.00146	0.0605	CcSEcCtD
Norepinephrine—SLC22A5—medulla oblongata—multiple sclerosis	0.00146	0.00953	CbGeAlD
Norepinephrine—Epinephrine—TNF—multiple sclerosis	0.00146	0.192	CrCbGaD
Norepinephrine—SLC22A3—central nervous system—multiple sclerosis	0.00146	0.00948	CbGeAlD
Norepinephrine—DRD2—midbrain—multiple sclerosis	0.00144	0.00935	CbGeAlD
Norepinephrine—ADRA2C—midbrain—multiple sclerosis	0.0014	0.00909	CbGeAlD
Norepinephrine—ADRA2C—spinal cord—multiple sclerosis	0.00136	0.00887	CbGeAlD
Norepinephrine—SLC22A5—midbrain—multiple sclerosis	0.00134	0.00871	CbGeAlD
Norepinephrine—SLC22A5—spinal cord—multiple sclerosis	0.0013	0.0085	CbGeAlD
Norepinephrine—SLC6A2—nervous system—multiple sclerosis	0.0013	0.00844	CbGeAlD
Norepinephrine—SLC6A2—central nervous system—multiple sclerosis	0.00125	0.00812	CbGeAlD
Norepinephrine—ADRA2A—medulla oblongata—multiple sclerosis	0.00122	0.00794	CbGeAlD
Norepinephrine—SLC22A1—brain—multiple sclerosis	0.00121	0.00787	CbGeAlD
Norepinephrine—ADRA1A—nervous system—multiple sclerosis	0.0012	0.00784	CbGeAlD
Norepinephrine—DRD2—nervous system—multiple sclerosis	0.00118	0.00769	CbGeAlD
Norepinephrine—ADRB1—brain—multiple sclerosis	0.00116	0.00758	CbGeAlD
Norepinephrine—ADRA1A—central nervous system—multiple sclerosis	0.00116	0.00755	CbGeAlD
Norepinephrine—SLC22A3—brain—multiple sclerosis	0.00116	0.00752	CbGeAlD
Norepinephrine—Bradycardia—Fingolimod—multiple sclerosis	0.00115	0.0476	CcSEcCtD
Norepinephrine—ADRA2C—nervous system—multiple sclerosis	0.00115	0.00747	CbGeAlD
Norepinephrine—DRD2—central nervous system—multiple sclerosis	0.00114	0.0074	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—multiple sclerosis	0.00113	0.00738	CbGeAlD
Norepinephrine—ADRA2A—midbrain—multiple sclerosis	0.00111	0.00725	CbGeAlD
Norepinephrine—DRD2—cerebellum—multiple sclerosis	0.00111	0.00723	CbGeAlD
Norepinephrine—ADRA2C—central nervous system—multiple sclerosis	0.00111	0.00719	CbGeAlD
Norepinephrine—ADRA2A—spinal cord—multiple sclerosis	0.00109	0.00708	CbGeAlD
Norepinephrine—ADRA2C—cerebellum—multiple sclerosis	0.00108	0.00703	CbGeAlD
Norepinephrine—SLC22A5—cerebellum—multiple sclerosis	0.00103	0.00674	CbGeAlD
Norepinephrine—SLC6A2—brain—multiple sclerosis	0.00099	0.00645	CbGeAlD
Norepinephrine—Extravasation—Mitoxantrone—multiple sclerosis	0.000962	0.0397	CcSEcCtD
Norepinephrine—ADRA1A—brain—multiple sclerosis	0.000921	0.00599	CbGeAlD
Norepinephrine—ADRA2A—nervous system—multiple sclerosis	0.000916	0.00596	CbGeAlD
Norepinephrine—DRD2—brain—multiple sclerosis	0.000902	0.00588	CbGeAlD
Norepinephrine—ADRA2A—central nervous system—multiple sclerosis	0.000882	0.00574	CbGeAlD
Norepinephrine—ADRA2C—brain—multiple sclerosis	0.000877	0.00571	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—multiple sclerosis	0.000862	0.00561	CbGeAlD
Norepinephrine—Hypertension—Fingolimod—multiple sclerosis	0.00085	0.0351	CcSEcCtD
Norepinephrine—SLC22A5—brain—multiple sclerosis	0.00084	0.00547	CbGeAlD
Norepinephrine—Dyspnoea—Fingolimod—multiple sclerosis	0.000717	0.0296	CcSEcCtD
Norepinephrine—ADRA2A—brain—multiple sclerosis	0.0007	0.00456	CbGeAlD
Norepinephrine—Extravasation—Betamethasone—multiple sclerosis	0.000659	0.0272	CcSEcCtD
Norepinephrine—Extravasation—Dexamethasone—multiple sclerosis	0.000659	0.0272	CcSEcCtD
Norepinephrine—Arrhythmia—Cladribine—multiple sclerosis	0.000573	0.0237	CcSEcCtD
Norepinephrine—Headache—Fingolimod—multiple sclerosis	0.000504	0.0208	CcSEcCtD
Norepinephrine—Extravasation—Methotrexate—multiple sclerosis	0.000479	0.0198	CcSEcCtD
Norepinephrine—Chest pain—Cladribine—multiple sclerosis	0.000475	0.0196	CcSEcCtD
Norepinephrine—Anxiety—Cladribine—multiple sclerosis	0.000474	0.0196	CcSEcCtD
Norepinephrine—Arrhythmia—Azathioprine—multiple sclerosis	0.000466	0.0192	CcSEcCtD
Norepinephrine—Sweating—Mitoxantrone—multiple sclerosis	0.00045	0.0186	CcSEcCtD
Norepinephrine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000441	0.0182	CcSEcCtD
Norepinephrine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000429	0.0177	CcSEcCtD
Norepinephrine—Dyspnoea—Cladribine—multiple sclerosis	0.000406	0.0168	CcSEcCtD
Norepinephrine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000377	0.0156	CcSEcCtD
Norepinephrine—Bradycardia—Prednisolone—multiple sclerosis	0.000352	0.0145	CcSEcCtD
Norepinephrine—Sweating—Methylprednisolone—multiple sclerosis	0.000339	0.014	CcSEcCtD
Norepinephrine—Bradycardia—Triamcinolone—multiple sclerosis	0.000324	0.0134	CcSEcCtD
Norepinephrine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000323	0.0133	CcSEcCtD
Norepinephrine—Hypertension—Mitoxantrone—multiple sclerosis	0.000317	0.0131	CcSEcCtD
Norepinephrine—Chest pain—Mitoxantrone—multiple sclerosis	0.000312	0.0129	CcSEcCtD
Norepinephrine—Anxiety—Mitoxantrone—multiple sclerosis	0.000311	0.0129	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisolone—multiple sclerosis	0.000309	0.0128	CcSEcCtD
Norepinephrine—Bradycardia—Betamethasone—multiple sclerosis	0.000294	0.0121	CcSEcCtD
Norepinephrine—Bradycardia—Dexamethasone—multiple sclerosis	0.000294	0.0121	CcSEcCtD
Norepinephrine—Vomiting—Cladribine—multiple sclerosis	0.00029	0.012	CcSEcCtD
Norepinephrine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00029	0.012	CcSEcCtD
Norepinephrine—Headache—Cladribine—multiple sclerosis	0.000286	0.0118	CcSEcCtD
Norepinephrine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000284	0.0117	CcSEcCtD
Norepinephrine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000284	0.0117	CcSEcCtD
Norepinephrine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000267	0.011	CcSEcCtD
Norepinephrine—Hypertension—Prednisolone—multiple sclerosis	0.00026	0.0107	CcSEcCtD
Norepinephrine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000258	0.0106	CcSEcCtD
Norepinephrine—Arrhythmia—Betamethasone—multiple sclerosis	0.000258	0.0106	CcSEcCtD
Norepinephrine—Bradycardia—Prednisone—multiple sclerosis	0.000256	0.0106	CcSEcCtD
Norepinephrine—Hypertension—Triamcinolone—multiple sclerosis	0.000239	0.00987	CcSEcCtD
Norepinephrine—Hypertension—Methylprednisolone—multiple sclerosis	0.000239	0.00985	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000238	0.00981	CcSEcCtD
Norepinephrine—Vomiting—Azathioprine—multiple sclerosis	0.000236	0.00973	CcSEcCtD
Norepinephrine—Anxiety—Methylprednisolone—multiple sclerosis	0.000234	0.00968	CcSEcCtD
Norepinephrine—Headache—Azathioprine—multiple sclerosis	0.000232	0.00959	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisone—multiple sclerosis	0.000225	0.00927	CcSEcCtD
Norepinephrine—Sweating—Methotrexate—multiple sclerosis	0.000224	0.00926	CcSEcCtD
Norepinephrine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000218	0.00902	CcSEcCtD
Norepinephrine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000218	0.009	CcSEcCtD
Norepinephrine—Hypertension—Betamethasone—multiple sclerosis	0.000217	0.00896	CcSEcCtD
Norepinephrine—Hypertension—Dexamethasone—multiple sclerosis	0.000217	0.00896	CcSEcCtD
Norepinephrine—Anxiety—Betamethasone—multiple sclerosis	0.000213	0.0088	CcSEcCtD
Norepinephrine—Anxiety—Dexamethasone—multiple sclerosis	0.000213	0.0088	CcSEcCtD
Norepinephrine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000201	0.00832	CcSEcCtD
Norepinephrine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000198	0.00819	CcSEcCtD
Norepinephrine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000198	0.00819	CcSEcCtD
Norepinephrine—Vomiting—Mitoxantrone—multiple sclerosis	0.00019	0.00786	CcSEcCtD
Norepinephrine—Hypertension—Prednisone—multiple sclerosis	0.000189	0.0078	CcSEcCtD
Norepinephrine—Headache—Mitoxantrone—multiple sclerosis	0.000188	0.00775	CcSEcCtD
Norepinephrine—Anxiety—Prednisone—multiple sclerosis	0.000186	0.00767	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000173	0.00713	CcSEcCtD
Norepinephrine—Chest pain—Methotrexate—multiple sclerosis	0.000156	0.00643	CcSEcCtD
Norepinephrine—Headache—Prednisolone—multiple sclerosis	0.000154	0.00636	CcSEcCtD
Norepinephrine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000144	0.00596	CcSEcCtD
Norepinephrine—Vomiting—Triamcinolone—multiple sclerosis	0.000144	0.00593	CcSEcCtD
Norepinephrine—Vomiting—Methylprednisolone—multiple sclerosis	0.000143	0.00592	CcSEcCtD
Norepinephrine—Headache—Triamcinolone—multiple sclerosis	0.000142	0.00585	CcSEcCtD
Norepinephrine—Headache—Methylprednisolone—multiple sclerosis	0.000141	0.00583	CcSEcCtD
Norepinephrine—Dyspnoea—Methotrexate—multiple sclerosis	0.000133	0.00549	CcSEcCtD
Norepinephrine—Vomiting—Dexamethasone—multiple sclerosis	0.00013	0.00538	CcSEcCtD
Norepinephrine—Vomiting—Betamethasone—multiple sclerosis	0.00013	0.00538	CcSEcCtD
Norepinephrine—Headache—Dexamethasone—multiple sclerosis	0.000128	0.0053	CcSEcCtD
Norepinephrine—Headache—Betamethasone—multiple sclerosis	0.000128	0.0053	CcSEcCtD
Norepinephrine—Vomiting—Prednisone—multiple sclerosis	0.000114	0.00469	CcSEcCtD
Norepinephrine—Headache—Prednisone—multiple sclerosis	0.000112	0.00462	CcSEcCtD
Norepinephrine—Vomiting—Methotrexate—multiple sclerosis	9.49e-05	0.00392	CcSEcCtD
Norepinephrine—Headache—Methotrexate—multiple sclerosis	9.35e-05	0.00386	CcSEcCtD
Norepinephrine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	3.86e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	3.84e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	3.8e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	3.8e-05	0.000116	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	3.79e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	3.78e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	3.78e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	3.76e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	3.75e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	3.73e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	3.72e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	3.72e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	3.71e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	3.7e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	3.69e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	3.68e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	3.67e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	3.65e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	3.63e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	3.56e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CD86—multiple sclerosis	3.55e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	3.52e-05	0.000108	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	3.5e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	3.5e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CD86—multiple sclerosis	3.48e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	3.47e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	3.46e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	3.45e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	3.43e-05	0.000105	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	3.43e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	3.42e-05	0.000105	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	3.41e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	3.41e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	3.4e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	3.39e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	3.38e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	3.38e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	3.37e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	3.36e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	3.32e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	3.3e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	3.29e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	3.29e-05	0.000101	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—APOE—multiple sclerosis	3.26e-05	9.97e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	3.24e-05	9.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	3.24e-05	9.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	3.24e-05	9.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	3.21e-05	9.81e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.2e-05	9.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	3.19e-05	9.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOE—multiple sclerosis	3.17e-05	9.7e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	3.17e-05	9.69e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	3.15e-05	9.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	3.15e-05	9.63e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	3.15e-05	9.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	3.14e-05	9.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	3.14e-05	9.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	3.12e-05	9.55e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	3.11e-05	9.51e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	3.11e-05	9.49e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	3.09e-05	9.45e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	3.09e-05	9.44e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	3.08e-05	9.42e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	3.08e-05	9.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	3.08e-05	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL2—multiple sclerosis	3.07e-05	9.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	3.07e-05	9.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	3.06e-05	9.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	3.06e-05	9.34e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	3.05e-05	9.33e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOE—multiple sclerosis	3.04e-05	9.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	3.04e-05	9.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	3.02e-05	9.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	3e-05	9.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	3e-05	9.16e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CD86—multiple sclerosis	2.99e-05	9.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	2.95e-05	9.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	2.94e-05	8.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	2.92e-05	8.92e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	2.9e-05	8.88e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	2.88e-05	8.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	2.88e-05	8.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	2.87e-05	8.78e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—multiple sclerosis	2.87e-05	8.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	2.85e-05	8.72e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	2.85e-05	8.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	2.85e-05	8.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	2.84e-05	8.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	2.83e-05	8.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	2.83e-05	8.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	2.81e-05	8.58e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—multiple sclerosis	2.81e-05	8.57e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—POMC—multiple sclerosis	2.8e-05	8.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	2.79e-05	8.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	2.75e-05	8.4e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.75e-05	8.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—POMC—multiple sclerosis	2.73e-05	8.33e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	2.72e-05	8.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	2.7e-05	8.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	2.67e-05	8.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	2.65e-05	8.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	2.65e-05	8.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	2.65e-05	8.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	2.63e-05	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	2.62e-05	8.01e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—POMC—multiple sclerosis	2.61e-05	7.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	2.61e-05	7.98e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	2.61e-05	7.97e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CD80—multiple sclerosis	2.59e-05	7.92e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	2.59e-05	7.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	2.59e-05	7.91e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	2.58e-05	7.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—multiple sclerosis	2.58e-05	7.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	2.57e-05	7.85e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ALB—multiple sclerosis	2.56e-05	7.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	2.55e-05	7.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	2.55e-05	7.79e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CD80—multiple sclerosis	2.54e-05	7.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	2.51e-05	7.68e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.5e-05	7.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	2.5e-05	7.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—multiple sclerosis	2.49e-05	7.6e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—POMC—multiple sclerosis	2.46e-05	7.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	2.44e-05	7.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	2.44e-05	7.44e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	2.41e-05	7.37e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—POMC—multiple sclerosis	2.41e-05	7.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—multiple sclerosis	2.41e-05	7.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	2.4e-05	7.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	2.4e-05	7.33e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MYC—multiple sclerosis	2.4e-05	7.33e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	2.39e-05	7.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	2.39e-05	7.3e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ALB—multiple sclerosis	2.38e-05	7.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	2.37e-05	7.24e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.37e-05	7.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	2.36e-05	7.22e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	2.36e-05	7.21e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	2.36e-05	7.21e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	2.35e-05	7.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.34e-05	7.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	2.34e-05	7.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	2.32e-05	7.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	2.32e-05	7.08e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	2.31e-05	7.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	2.28e-05	6.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	2.24e-05	6.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	2.23e-05	6.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—POMC—multiple sclerosis	2.22e-05	6.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	2.2e-05	6.71e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	2.19e-05	6.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.18e-05	6.67e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CD80—multiple sclerosis	2.18e-05	6.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	2.17e-05	6.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	2.16e-05	6.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.15e-05	6.57e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	2.14e-05	6.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	2.1e-05	6.41e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—POMC—multiple sclerosis	2.07e-05	6.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	2.03e-05	6.19e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	2.02e-05	6.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—multiple sclerosis	2.02e-05	6.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	2e-05	6.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.99e-05	6.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.99e-05	6.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.99e-05	6.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.98e-05	6.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.95e-05	5.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.95e-05	5.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.91e-05	5.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	1.89e-05	5.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.85e-05	5.66e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.84e-05	5.62e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2—multiple sclerosis	1.82e-05	5.57e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	1.81e-05	5.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.81e-05	5.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.8e-05	5.52e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—multiple sclerosis	1.8e-05	5.51e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.8e-05	5.49e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2—multiple sclerosis	1.78e-05	5.44e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.77e-05	5.42e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	1.77e-05	5.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.77e-05	5.41e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	1.72e-05	5.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.71e-05	5.22e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	1.69e-05	5.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.69e-05	5.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	1.68e-05	5.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.68e-05	5.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.66e-05	5.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.65e-05	5.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.65e-05	5.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	1.6e-05	4.88e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.57e-05	4.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.56e-05	4.78e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.56e-05	4.76e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	1.53e-05	4.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.53e-05	4.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.53e-05	4.67e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.52e-05	4.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.52e-05	4.64e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	1.5e-05	4.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.47e-05	4.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.47e-05	4.48e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.45e-05	4.42e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—multiple sclerosis	1.42e-05	4.35e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—multiple sclerosis	1.42e-05	4.35e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	1.42e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	1.42e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	1.41e-05	4.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	1.41e-05	4.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	1.4e-05	4.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.39e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	1.39e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—multiple sclerosis	1.39e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	1.39e-05	4.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.38e-05	4.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.37e-05	4.18e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	1.36e-05	4.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.36e-05	4.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	1.32e-05	4.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	1.32e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	1.3e-05	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.3e-05	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	1.29e-05	3.95e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	1.29e-05	3.94e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.29e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	1.27e-05	3.88e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.24e-05	3.79e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—POMC—multiple sclerosis	1.22e-05	3.74e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.2e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.19e-05	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	1.18e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.17e-05	3.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.15e-05	3.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.15e-05	3.52e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.15e-05	3.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.13e-05	3.44e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—multiple sclerosis	1.11e-05	3.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.07e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—multiple sclerosis	1.07e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.07e-05	3.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.06e-05	3.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1.05e-05	3.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—multiple sclerosis	1.05e-05	3.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	9.91e-06	3.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	9.75e-06	2.98e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—multiple sclerosis	8.99e-06	2.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	8.66e-06	2.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	8.05e-06	2.46e-05	CbGpPWpGaD
